Frequencies for first 10,000 rows of indi_pt variable in indi2008q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL ABSCESS | 2 0.02 0.02 ABDOMINAL DISCOMFORT | 1 0.01 0.03 ABDOMINAL INFECTION | 1 0.01 0.04 ABDOMINAL PAIN | 12 0.12 0.16 ABDOMINAL PAIN UPPER | 5 0.05 0.21 ABNORMAL BEHAVIOUR | 5 0.05 0.26 ACARODERMATITIS | 1 0.01 0.27 ACCIDENTAL EXPOSURE | 3 0.03 0.30 ACINETOBACTER INFECTION | 1 0.01 0.31 ACNE | 138 1.38 1.69 ACNE CONGLOBATA | 1 0.01 1.70 ACNE CYSTIC | 15 0.15 1.85 ACQUIRED IMMUNODEFICIENCY SYNDROME | 5 0.05 1.90 ACTINIC KERATOSIS | 2 0.02 1.92 ACTIVATED PARTIAL THROMBOPLASTIN TIME | 1 0.01 1.93 ACUTE CORONARY SYNDROME | 2 0.02 1.95 ACUTE GRAFT VERSUS HOST DISEASE | 1 0.01 1.96 ACUTE LEUKAEMIA | 4 0.04 2.00 ACUTE LYMPHOCYTIC LEUKAEMIA | 35 0.35 2.35 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 1 0.01 2.36 ACUTE MYELOID LEUKAEMIA | 38 0.38 2.74 ACUTE MYOCARDIAL INFARCTION | 5 0.05 2.79 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 2.80 ACUTE PSYCHOSIS | 1 0.01 2.81 ACUTE SINUSITIS | 2 0.02 2.83 ADDISON'S DISEASE | 1 0.01 2.84 ADVERSE DRUG REACTION | 1 0.01 2.85 AFFECTIVE DISORDER | 7 0.07 2.92 AGEUSIA | 1 0.01 2.93 AGGRESSION | 1 0.01 2.94 AGITATION | 8 0.08 3.02 ALCOHOL ABUSE | 1 0.01 3.03 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 3.04 ALCOHOLISM | 1 0.01 3.05 ALLERGY PROPHYLAXIS | 1 0.01 3.06 ALLERGY TO ANIMAL | 1 0.01 3.07 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 3.08 ALOPECIA | 4 0.04 3.12 ALOPECIA AREATA | 1 0.01 3.13 ALOPECIA SCARRING | 1 0.01 3.14 ALPHA-1 ANTI-TRYPSIN DEFICIENCY | 4 0.04 3.18 AMYLOIDOSIS | 8 0.08 3.26 ANAEMIA | 16 0.16 3.42 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 3.43 ANAESTHESIA | 58 0.58 4.01 ANALGESIA | 12 0.12 4.13 ANALGESIC THERAPY | 5 0.05 4.18 ANGINA PECTORIS | 21 0.21 4.39 ANGINA UNSTABLE | 2 0.02 4.41 ANGIOEDEMA | 2 0.02 4.43 ANGIOGRAM | 7 0.07 4.50 ANGIOGRAM PERIPHERAL | 1 0.01 4.51 ANGIOPATHY | 1 0.01 4.52 ANGIOPLASTY | 3 0.03 4.55 ANKYLOSING SPONDYLITIS | 17 0.17 4.72 ANOGENITAL WARTS | 1 0.01 4.73 ANORECTAL DISCOMFORT | 1 0.01 4.74 ANOREXIA NERVOSA | 2 0.02 4.76 ANTACID THERAPY | 2 0.02 4.78 ANTI-INFECTIVE THERAPY | 3 0.03 4.81 ANTIALLERGIC THERAPY | 1 0.01 4.82 ANTIBIOTIC PROPHYLAXIS | 3 0.03 4.85 ANTIBIOTIC THERAPY | 2 0.02 4.87 ANTICOAGULANT THERAPY | 10 0.10 4.97 ANTIDEPRESSANT THERAPY | 7 0.07 5.04 ANTIEMETIC SUPPORTIVE CARE | 5 0.05 5.09 ANTIFUNGAL PROPHYLAXIS | 5 0.05 5.14 ANTIINFLAMMATORY THERAPY | 1 0.01 5.15 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 5.16 ANTIPLATELET THERAPY | 5 0.05 5.21 ANTIPYRESIS | 1 0.01 5.22 ANTIVIRAL PROPHYLAXIS | 7 0.07 5.29 ANXIETY | 70 0.70 5.99 AORTIC VALVE REPLACEMENT | 1 0.01 6.00 APATHY | 1 0.01 6.01 APLASTIC ANAEMIA | 1 0.01 6.02 APPENDICITIS | 1 0.01 6.03 APPETITE DISORDER | 2 0.02 6.05 APPLICATION SITE ANAESTHESIA | 1 0.01 6.06 ARRHYTHMIA | 6 0.06 6.12 ARTERIAL STENOSIS | 1 0.01 6.13 ARTERIAL THROMBOSIS | 1 0.01 6.14 ARTERIOGRAM CORONARY | 5 0.05 6.19 ARTERIOGRAM RENAL | 1 0.01 6.20 ARTERIOSCLEROSIS | 1 0.01 6.21 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 6.22 ARTERIOVENOUS FISTULA SITE COMPLICATION | 1 0.01 6.23 ARTERIOVENOUS FISTULA THROMBOSIS | 1 0.01 6.24 ARTERITIS | 1 0.01 6.25 ARTHRALGIA | 15 0.15 6.40 ARTHRITIS | 29 0.29 6.69 ARTHROPATHY | 3 0.03 6.72 ASPARTATE AMINOTRANSFERASE INCREASED | 1 0.01 6.73 ASPERGILLOSIS | 5 0.05 6.78 ASTEATOSIS | 1 0.01 6.79 ASTHMA | 209 2.09 8.88 ASTHMA EXERCISE INDUCED | 3 0.03 8.91 ASTROCYTOMA | 1 0.01 8.92 ATRIAL FIBRILLATION | 46 0.46 9.38 ATRIAL FLUTTER | 3 0.03 9.41 ATROPHIC VULVOVAGINITIS | 1 0.01 9.42 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 24 0.24 9.66 AUTISM | 2 0.02 9.68 AUTISM SPECTRUM DISORDER | 2 0.02 9.70 AUTOIMMUNE DISORDER | 3 0.03 9.73 AUTOIMMUNE THYROIDITIS | 1 0.01 9.74 B-CELL LYMPHOMA | 20 0.20 9.94 B-CELL SMALL LYMPHOCYTIC LYMPHOMA | 6 0.06 10.00 BACK PAIN | 71 0.71 10.71 BACTERAEMIA | 2 0.02 10.73 BACTERIAL INFECTION | 2 0.02 10.75 BARRETT'S OESOPHAGUS | 1 0.01 10.76 BASAL CELL NAEVUS SYNDROME | 1 0.01 10.77 BASEDOW'S DISEASE | 2 0.02 10.79 BEHCET'S SYNDROME | 4 0.04 10.83 BENIGN PROSTATIC HYPERPLASIA | 18 0.18 11.01 BILE DUCT CANCER | 3 0.03 11.04 BIPOLAR DISORDER | 35 0.35 11.39 BIPOLAR I DISORDER | 16 0.16 11.55 BLADDER CANCER | 16 0.16 11.71 BLADDER DISORDER | 3 0.03 11.74 BLADDER SPASM | 1 0.01 11.75 BLOOD CHOLESTEROL | 12 0.12 11.87 BLOOD CHOLESTEROL INCREASED | 43 0.43 12.30 BLOOD GLUCOSE | 1 0.01 12.31 BLOOD GLUCOSE ABNORMAL | 1 0.01 12.32 BLOOD GROWTH HORMONE DECREASED | 1 0.01 12.33 BLOOD LUTEINISING HORMONE ABNORMAL | 1 0.01 12.34 BLOOD POTASSIUM DECREASED | 3 0.03 12.37 BLOOD PRESSURE | 22 0.22 12.59 BLOOD PRESSURE ABNORMAL | 4 0.04 12.63 BLOOD PRESSURE INCREASED | 4 0.04 12.67 BLOOD PRESSURE MANAGEMENT | 1 0.01 12.68 BLOOD TRIGLYCERIDES INCREASED | 3 0.03 12.71 BODY HEIGHT BELOW NORMAL | 2 0.02 12.73 BODY TEMPERATURE INCREASED | 3 0.03 12.76 BONE DENSITOMETRY | 1 0.01 12.77 BONE DISORDER | 2 0.02 12.79 BONE MARROW CONDITIONING REGIMEN | 7 0.07 12.86 BONE MARROW TRANSPLANT | 3 0.03 12.89 BONE PAIN | 1 0.01 12.90 BONE SARCOMA | 2 0.02 12.92 BORDERLINE PERSONALITY DISORDER | 1 0.01 12.93 BRAIN STEM HAEMORRHAGE | 1 0.01 12.94 BREAKTHROUGH PAIN | 9 0.09 13.03 BREAST CANCER | 152 1.52 14.55 BREAST CANCER FEMALE | 1 0.01 14.56 BREAST CANCER IN SITU | 2 0.02 14.58 BREAST CANCER METASTATIC | 28 0.28 14.86 BREAST LUMP REMOVAL | 1 0.01 14.87 BREAST NEOPLASM | 2 0.02 14.89 BREATH ODOUR | 1 0.01 14.90 BRONCHIAL HYPERREACTIVITY | 1 0.01 14.91 BRONCHIECTASIS | 1 0.01 14.92 BRONCHIOLOALVEOLAR CARCINOMA | 1 0.01 14.93 BRONCHITIS | 25 0.25 15.18 BRONCHITIS CHRONIC | 3 0.03 15.21 BRONCHOPULMONARY ASPERGILLOSIS | 3 0.03 15.24 BRONCHOSPASM | 4 0.04 15.28 BRUTON'S AGAMMAGLOBULINAEMIA | 1 0.01 15.29 CANCER PAIN | 13 0.13 15.42 CANDIDIASIS | 5 0.05 15.47 CARCINOMA IN SITU OF BLADDER | 1 0.01 15.48 CARDIAC DISORDER | 22 0.22 15.70 CARDIAC FAILURE | 18 0.18 15.88 CARDIAC FAILURE CHRONIC | 7 0.07 15.95 CARDIAC FAILURE CONGESTIVE | 9 0.09 16.04 CARDIAC INFECTION | 1 0.01 16.05 CARDIAC OPERATION | 5 0.05 16.10 CARDIAC STRESS TEST ABNORMAL | 1 0.01 16.11 CARDIAC VENTRICULOGRAM | 1 0.01 16.12 CARDIOVASCULAR DISORDER | 5 0.05 16.17 CARDIOVASCULAR EVENT PROPHYLAXIS | 10 0.10 16.27 CATARACT | 3 0.03 16.30 CATHETER RELATED INFECTION | 1 0.01 16.31 CATHETER SEPSIS | 3 0.03 16.34 CATHETER THROMBOSIS | 1 0.01 16.35 CATHETERISATION CARDIAC | 5 0.05 16.40 CELLULITIS | 4 0.04 16.44 CENTRAL NERVOUS SYSTEM LYMPHOMA | 2 0.02 16.46 CEREBRAL ARTERY EMBOLISM | 1 0.01 16.47 CEREBRAL INFARCTION | 8 0.08 16.55 CEREBRAL ISCHAEMIA | 1 0.01 16.56 CEREBRAL PALSY | 1 0.01 16.57 CEREBROVASCULAR ACCIDENT | 9 0.09 16.66 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 1 0.01 16.67 CEREBROVASCULAR DISORDER | 1 0.01 16.68 CERVIX CARCINOMA | 3 0.03 16.71 CHELATION THERAPY | 2 0.02 16.73 CHEMOTHERAPY | 18 0.18 16.91 CHEST DISCOMFORT | 1 0.01 16.92 CHEST PAIN | 5 0.05 16.97 CHEST X-RAY ABNORMAL | 1 0.01 16.98 CHILLS | 1 0.01 16.99 CHOLANGITIS ACUTE | 1 0.01 17.00 CHOLELITHIASIS | 1 0.01 17.01 CHOLESTASIS | 2 0.02 17.03 CHOROID PLEXUS CARCINOMA | 2 0.02 17.05 CHRONIC HEPATITIS | 1 0.01 17.06 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 17.07 CHRONIC LYMPHOCYTIC LEUKAEMIA | 24 0.24 17.31 CHRONIC MYELOID LEUKAEMIA | 32 0.32 17.63 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 42 0.42 18.05 CHRONIC SINUSITIS | 1 0.01 18.06 CIRCADIAN RHYTHM SLEEP DISORDER | 3 0.03 18.09 CITROBACTER INFECTION | 1 0.01 18.10 CLUSTER HEADACHE | 3 0.03 18.13 COAGULATION TIME PROLONGED | 1 0.01 18.14 COAGULOPATHY | 7 0.07 18.21 COLITIS | 2 0.02 18.23 COLITIS ULCERATIVE | 9 0.09 18.32 COLON CANCER | 25 0.25 18.57 COLON CANCER METASTATIC | 18 0.18 18.75 COLONOSCOPY | 2 0.02 18.77 COLONY STIMULATING FACTOR PROPHYLAXIS | 2 0.02 18.79 COLORECTAL CANCER | 15 0.15 18.94 COLORECTAL CANCER METASTATIC | 21 0.21 19.15 COMPLEX REGIONAL PAIN SYNDROME | 4 0.04 19.19 COMPLICATIONS OF TRANSPLANTED KIDNEY | 2 0.02 19.21 COMPUTERISED TOMOGRAM | 46 0.46 19.67 COMPUTERISED TOMOGRAM ABDOMEN | 21 0.21 19.88 COMPUTERISED TOMOGRAM HEAD | 2 0.02 19.90 COMPUTERISED TOMOGRAM THORAX | 5 0.05 19.95 CONFUSIONAL STATE | 1 0.01 19.96 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 19.97 CONJUNCTIVITIS | 1 0.01 19.98 CONNECTIVE TISSUE DISORDER | 2 0.02 20.00 CONSTIPATION | 26 0.26 20.26 CONTRACEPTION | 123 1.23 21.49 CONVULSION | 30 0.30 21.79 CONVULSION PROPHYLAXIS | 1 0.01 21.80 CORD BLOOD TRANSPLANT THERAPY | 4 0.04 21.84 CORONARY ARTERIAL STENT INSERTION | 4 0.04 21.88 CORONARY ARTERY BYPASS | 3 0.03 21.91 CORONARY ARTERY DISEASE | 9 0.09 22.00 CORRECTIVE LENS USER | 1 0.01 22.01 COUGH | 12 0.12 22.13 CRANIOPHARYNGIOMA | 1 0.01 22.14 CROHN'S DISEASE | 64 0.64 22.78 CYCLIC VOMITING SYNDROME | 1 0.01 22.79 CYCLOTHYMIC DISORDER | 2 0.02 22.81 CYST | 1 0.01 22.82 CYSTIC FIBROSIS | 1 0.01 22.83 CYSTINOSIS | 1 0.01 22.84 CYSTITIS | 2 0.02 22.86 CYSTITIS INTERSTITIAL | 17 0.17 23.03 CYTOMEGALOVIRUS INFECTION | 2 0.02 23.05 DEATH | 1 0.01 23.06 DECREASED APPETITE | 2 0.02 23.08 DEEP VEIN THROMBOSIS | 10 0.10 23.18 DEHYDRATION | 1 0.01 23.19 DELIRIUM | 1 0.01 23.20 DELUSION | 2 0.02 23.22 DELUSIONAL DISORDER, PERSECUTORY TYPE | 2 0.02 23.24 DEMENTIA | 7 0.07 23.31 DEMENTIA ALZHEIMER'S TYPE | 20 0.20 23.51 DENTAL CARE | 3 0.03 23.54 DENTAL DISCOMFORT | 1 0.01 23.55 DENTAL DISORDER PROPHYLAXIS | 3 0.03 23.58 DEPENDENCE | 1 0.01 23.59 DEPRESSION | 194 1.94 25.53 DEPRESSIVE SYMPTOM | 1 0.01 25.54 DERMATITIS | 8 0.08 25.62 DERMATITIS ATOPIC | 4 0.04 25.66 DERMATITIS CONTACT | 1 0.01 25.67 DERMATOPHYTOSIS | 1 0.01 25.68 DIABETES INSIPIDUS | 1 0.01 25.69 DIABETES MELLITUS | 140 1.40 27.09 DIABETIC NEPHROPATHY | 2 0.02 27.11 DIABETIC NEUROPATHY | 5 0.05 27.16 DIAGNOSTIC PROCEDURE | 3 0.03 27.19 DIALYSIS | 4 0.04 27.23 DIARRHOEA | 13 0.13 27.36 DIFFUSE LARGE B-CELL LYMPHOMA | 11 0.11 27.47 DISEASE PROGRESSION | 2 0.02 27.49 DISSEMINATED INTRAVASCULAR COAGULATION | 2 0.02 27.51 DISTURBANCE IN ATTENTION | 1 0.01 27.52 DIURETIC THERAPY | 4 0.04 27.56 DIVERTICULITIS | 2 0.02 27.58 DIZZINESS | 2 0.02 27.60 DRUG ABUSE | 4 0.04 27.64 DRUG DEPENDENCE | 33 0.33 27.97 DRUG EXPOSURE DURING PREGNANCY | 33 0.33 28.30 DRUG THERAPY | 1 0.01 28.31 DRUG USE FOR UNKNOWN INDICATION | 1,998 19.98 48.29 DRUG WITHDRAWAL MAINTENANCE THERAPY | 3 0.03 48.32 DRUG WITHDRAWAL SYNDROME | 1 0.01 48.33 DRY EYE | 7 0.07 48.40 DRY MOUTH | 2 0.02 48.42 DRY SKIN | 3 0.03 48.45 DUCHENNE MUSCULAR DYSTROPHY | 4 0.04 48.49 DUODENAL ULCER | 1 0.01 48.50 DWARFISM | 1 0.01 48.51 DYSAESTHESIA | 1 0.01 48.52 DYSLIPIDAEMIA | 10 0.10 48.62 DYSMENORRHOEA | 4 0.04 48.66 DYSPEPSIA | 20 0.20 48.86 DYSPNOEA | 3 0.03 48.89 DYSTONIA | 5 0.05 48.94 DYSURIA | 1 0.01 48.95 EAR DISORDER | 1 0.01 48.96 EAR INFECTION | 3 0.03 48.99 ECZEMA | 4 0.04 49.03 EFFUSION | 1 0.01 49.04 EMPHYSEMA | 9 0.09 49.13 ENDOCARDITIS | 2 0.02 49.15 ENDOMETRIAL CANCER | 1 0.01 49.16 ENDOMETRIOSIS | 2 0.02 49.18 ENDOTRACHEAL INTUBATION | 1 0.01 49.19 ENERGY INCREASED | 1 0.01 49.20 ENTERAL NUTRITION | 1 0.01 49.21 ENTEROCOCCAL INFECTION | 3 0.03 49.24 ENTEROCOLITIS | 1 0.01 49.25 EPIDERMAL GROWTH FACTOR RECEPTOR INCR.. | 1 0.01 49.26 EPIDURAL ANAESTHESIA | 6 0.06 49.32 EPIGASTRIC DISCOMFORT | 1 0.01 49.33 EPILEPSY | 43 0.43 49.76 ERECTILE DYSFUNCTION | 11 0.11 49.87 EROSIVE DUODENITIS | 2 0.02 49.89 ESCHERICHIA INFECTION | 2 0.02 49.91 ESSENTIAL HYPERTENSION | 9 0.09 50.00 ESSENTIAL TREMOR | 1 0.01 50.01 EVIDENCE BASED TREATMENT | 1 0.01 50.02 EWING'S SARCOMA | 1 0.01 50.03 EX-SMOKER | 6 0.06 50.09 EXOPHTHALMOS | 2 0.02 50.11 EXTRAPYRAMIDAL DISORDER | 1 0.01 50.12 FABRY'S DISEASE | 1 0.01 50.13 FACIAL NEURALGIA | 3 0.03 50.16 FACIAL SPASM | 1 0.01 50.17 FALL | 1 0.01 50.18 FATIGUE | 3 0.03 50.21 FEMALE REPRODUCTIVE NEOPLASM | 3 0.03 50.24 FIBROMYALGIA | 14 0.14 50.38 FLATULENCE | 2 0.02 50.40 FLUID REPLACEMENT | 1 0.01 50.41 FLUID RETENTION | 3 0.03 50.44 FOLATE DEFICIENCY | 2 0.02 50.46 FOLLICULITIS | 2 0.02 50.48 FOOD POISONING | 1 0.01 50.49 FOOT FRACTURE | 1 0.01 50.50 FOREIGN TRAVEL | 1 0.01 50.51 FRACTURE | 1 0.01 50.52 FUNGAL INFECTION | 3 0.03 50.55 GALLBLADDER CANCER | 1 0.01 50.56 GALLBLADDER CANCER NON-RESECTABLE | 1 0.01 50.57 GALLBLADDER CANCER STAGE IV | 2 0.02 50.59 GALLBLADDER DISORDER | 1 0.01 50.60 GASTRIC CANCER | 15 0.15 50.75 GASTRIC DISORDER | 4 0.04 50.79 GASTRIC ULCER | 11 0.11 50.90 GASTRINOMA | 1 0.01 50.91 GASTRITIS | 19 0.19 51.10 GASTRITIS PROPHYLAXIS | 6 0.06 51.16 GASTROENTERITIS | 5 0.05 51.21 GASTROINTESTINAL DISORDER | 6 0.06 51.27 GASTROINTESTINAL DISORDER THERAPY | 5 0.05 51.32 GASTROINTESTINAL HAEMORRHAGE | 3 0.03 51.35 GASTROINTESTINAL HYPERMOTILITY | 2 0.02 51.37 GASTROINTESTINAL PAIN | 1 0.01 51.38 GASTROINTESTINAL STROMAL TUMOUR | 7 0.07 51.45 GASTROOESOPHAGEAL REFLUX DISEASE | 50 0.50 51.95 GAUCHER'S DISEASE | 3 0.03 51.98 GENERAL ANAESTHESIA | 36 0.36 52.34 GENITAL HERPES | 1 0.01 52.35 GERM CELL CANCER | 8 0.08 52.43 GINGIVAL INFECTION | 1 0.01 52.44 GLAUCOMA | 5 0.05 52.49 GLIOBLASTOMA | 3 0.03 52.52 GLIOBLASTOMA MULTIFORME | 10 0.10 52.62 GLIOMA | 3 0.03 52.65 GLOMERULONEPHRITIS PROLIFERATIVE | 3 0.03 52.68 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 52.69 GLYCOGEN STORAGE DISEASE TYPE II | 3 0.03 52.72 GOUT | 7 0.07 52.79 GRAFT VERSUS HOST DISEASE | 8 0.08 52.87 GRAND MAL CONVULSION | 5 0.05 52.92 GROWTH HORMONE DEFICIENCY | 14 0.14 53.06 GROWTH RETARDATION | 2 0.02 53.08 GUTTATE PSORIASIS | 1 0.01 53.09 HAEMARTHROSIS | 2 0.02 53.11 HAEMATOCHEZIA | 1 0.01 53.12 HAEMATOLOGICAL MALIGNANCY | 5 0.05 53.17 HAEMATOMA | 1 0.01 53.18 HAEMATURIA | 1 0.01 53.19 HAEMODIALYSIS | 4 0.04 53.23 HAEMOPHILIA | 3 0.03 53.26 HAEMORRHAGE | 2 0.02 53.28 HAEMORRHOIDS | 1 0.01 53.29 HAEMOSIDEROSIS | 1 0.01 53.30 HAIRY CELL LEUKAEMIA | 1 0.01 53.31 HALLUCINATION | 2 0.02 53.33 HALLUCINATION, AUDITORY | 1 0.01 53.34 HEADACHE | 21 0.21 53.55 HEART RATE | 2 0.02 53.57 HEART RATE DECREASED | 1 0.01 53.58 HEART TRANSPLANT | 8 0.08 53.66 HELICOBACTER INFECTION | 9 0.09 53.75 HEMIPARESIS | 1 0.01 53.76 HEPARIN-INDUCED THROMBOCYTOPENIA | 5 0.05 53.81 HEPATIC CANCER METASTATIC | 4 0.04 53.85 HEPATIC CIRRHOSIS | 2 0.02 53.87 HEPATIC ENCEPHALOPATHY | 2 0.02 53.89 HEPATIC FAILURE | 3 0.03 53.92 HEPATIC FUNCTION ABNORMAL | 3 0.03 53.95 HEPATIC NEOPLASM MALIGNANT | 10 0.10 54.05 HEPATITIS | 2 0.02 54.07 HEPATITIS B | 5 0.05 54.12 HEPATITIS C | 120 1.20 55.32 HEPATITIS C VIRUS | 8 0.08 55.40 HEPATITIS VIRAL | 1 0.01 55.41 HEREDITARY HAEMORRHAGIC TELANGIECTASIA | 2 0.02 55.43 HERPES SIMPLEX | 1 0.01 55.44 HERPES VIRUS INFECTION | 1 0.01 55.45 HERPES ZOSTER | 18 0.18 55.63 HIATUS HERNIA | 2 0.02 55.65 HICCUPS | 1 0.01 55.66 HISTIOCYTOSIS HAEMATOPHAGIC | 4 0.04 55.70 HIV INFECTION | 202 2.02 57.72 HIV TEST POSITIVE | 2 0.02 57.74 HODGKIN'S DISEASE | 3 0.03 57.77 HORMONE REPLACEMENT THERAPY | 99 0.99 58.76 HOT FLUSH | 3 0.03 58.79 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 2 0.02 58.81 HUNTINGTON'S CHOREA | 5 0.05 58.86 HYPERCALCAEMIA OF MALIGNANCY | 1 0.01 58.87 HYPERCHLORAEMIA | 1 0.01 58.88 HYPERCHOLESTEROLAEMIA | 42 0.42 59.30 HYPEREOSINOPHILIC SYNDROME | 1 0.01 59.31 HYPERGLYCAEMIA | 2 0.02 59.33 HYPERLIPIDAEMIA | 39 0.39 59.72 HYPERPARATHYROIDISM | 1 0.01 59.73 HYPERPARATHYROIDISM SECONDARY | 3 0.03 59.76 HYPERPHOSPHATAEMIA | 1 0.01 59.77 HYPERPLASIA | 1 0.01 59.78 HYPERPROLACTINAEMIA | 1 0.01 59.79 HYPERSENSITIVITY | 42 0.42 60.21 HYPERTENSION | 310 3.10 63.31 HYPERTENSIVE ENCEPHALOPATHY | 1 0.01 63.32 HYPERTHYROIDISM | 6 0.06 63.38 HYPERTONIC BLADDER | 4 0.04 63.42 HYPERTRIGLYCERIDAEMIA | 5 0.05 63.47 HYPERTROPHY | 1 0.01 63.48 HYPERURICAEMIA | 8 0.08 63.56 HYPOAESTHESIA | 2 0.02 63.58 HYPOGLYCAEMIA | 1 0.01 63.59 HYPOKALAEMIA | 1 0.01 63.60 HYPONATRAEMIA | 1 0.01 63.61 HYPOPARATHYROIDISM | 2 0.02 63.63 HYPOPITUITARISM | 4 0.04 63.67 HYPOTENSION | 2 0.02 63.69 HYPOTHYROIDISM | 20 0.20 63.89 HYPOTONIA | 1 0.01 63.90 HYSTERECTOMY | 2 0.02 63.92 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 63.93 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 3 0.03 63.96 ILL-DEFINED DISORDER | 7 0.07 64.03 IMMUNE SYSTEM DISORDER | 1 0.01 64.04 IMMUNISATION | 7 0.07 64.11 IMMUNODEFICIENCY | 1 0.01 64.12 IMMUNOSUPPRESSANT DRUG THERAPY | 9 0.09 64.21 IMMUNOSUPPRESSION | 9 0.09 64.30 IMPULSE-CONTROL DISORDER | 1 0.01 64.31 IN VITRO FERTILISATION | 6 0.06 64.37 INDUCTION OF ANAESTHESIA | 3 0.03 64.40 INDWELLING CATHETER MANAGEMENT | 4 0.04 64.44 INFECTED SKIN ULCER | 1 0.01 64.45 INFECTION | 16 0.16 64.61 INFECTION PROPHYLAXIS | 10 0.10 64.71 INFILTRATION ANAESTHESIA | 1 0.01 64.72 INFLAMMATION | 8 0.08 64.80 INFLAMMATORY BOWEL DISEASE | 5 0.05 64.85 INFLUENZA | 20 0.20 65.05 INFLUENZA LIKE ILLNESS | 2 0.02 65.07 INITIAL INSOMNIA | 19 0.19 65.26 INJURY | 1 0.01 65.27 INSOMNIA | 185 1.85 67.12 INSOMNIA RELATED TO ANOTHER MENTAL CO.. | 1 0.01 67.13 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 3 0.03 67.16 INTERMITTENT CLAUDICATION | 3 0.03 67.19 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 67.20 INTRAOCULAR PRESSURE INCREASED | 1 0.01 67.21 INTRAOPERATIVE CARE | 2 0.02 67.23 INTRAVENOUS CATHETER MANAGEMENT | 3 0.03 67.26 IRON DEFICIENCY ANAEMIA | 1 0.01 67.27 IRON METABOLISM DISORDER | 2 0.02 67.29 IRON OVERLOAD | 12 0.12 67.41 IRRITABILITY | 1 0.01 67.42 IRRITABLE BOWEL SYNDROME | 5 0.05 67.47 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 4 0.04 67.51 ISCHAEMIC STROKE | 2 0.02 67.53 JOINT INJURY | 1 0.01 67.54 JOINT PROSTHESIS USER | 1 0.01 67.55 JUVENILE ARTHRITIS | 3 0.03 67.58 KIDNEY INFECTION | 1 0.01 67.59 KLEBSIELLA INFECTION | 1 0.01 67.60 KNEE OPERATION | 1 0.01 67.61 LABOUR PAIN | 1 0.01 67.62 LACUNAR INFARCTION | 3 0.03 67.65 LARGE INTESTINE CARCINOMA | 4 0.04 67.69 LARYNGEAL CANCER | 2 0.02 67.71 LAXATIVE SUPPORTIVE CARE | 3 0.03 67.74 LEUKAEMIA | 3 0.03 67.77 LEUKOPENIA | 3 0.03 67.80 LIBIDO DECREASED | 1 0.01 67.81 LICE INFESTATION | 4 0.04 67.85 LIP DISORDER | 1 0.01 67.86 LIPIDS | 2 0.02 67.88 LIPIDS ABNORMAL | 3 0.03 67.91 LIPIDS INCREASED | 1 0.01 67.92 LIPODYSTROPHY ACQUIRED | 8 0.08 68.00 LIVER ABSCESS | 1 0.01 68.01 LIVER AND SMALL INTESTINE TRANSPLANT | 3 0.03 68.04 LIVER DISORDER | 1 0.01 68.05 LIVER TRANSPLANT | 3 0.03 68.08 LIVER TRANSPLANT REJECTION | 3 0.03 68.11 LOCAL ANAESTHESIA | 1 0.01 68.12 LOSS OF CONSCIOUSNESS | 1 0.01 68.13 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 68.14 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 68.17 LUMBAR RADICULOPATHY | 5 0.05 68.22 LUMBAR SPINAL STENOSIS | 2 0.02 68.24 LUNG ADENOCARCINOMA | 6 0.06 68.30 LUNG ADENOCARCINOMA STAGE II | 1 0.01 68.31 LUNG CANCER METASTATIC | 2 0.02 68.33 LUNG DISORDER | 2 0.02 68.35 LUNG INFECTION | 2 0.02 68.37 LUNG NEOPLASM | 1 0.01 68.38 LUNG NEOPLASM MALIGNANT | 15 0.15 68.53 LUPUS NEPHRITIS | 4 0.04 68.57 LYME DISEASE | 1 0.01 68.58 LYMPHADENOPATHY | 1 0.01 68.59 LYMPHATIC DISORDER | 1 0.01 68.60 LYMPHOMA | 2 0.02 68.62 MACULAR DEGENERATION | 10 0.10 68.72 MAJOR DEPRESSION | 6 0.06 68.78 MALAISE | 2 0.02 68.80 MALARIA PROPHYLAXIS | 4 0.04 68.84 MALIGNANT GLIOMA | 3 0.03 68.87 MALIGNANT HEPATOBILIARY NEOPLASM | 1 0.01 68.88 MALIGNANT HISTIOCYTOSIS | 9 0.09 68.97 MALIGNANT MELANOMA | 11 0.11 69.08 MALIGNANT NEOPLASM OF RENAL PELVIS | 1 0.01 69.09 MALIGNANT NEOPLASM PROGRESSION | 1 0.01 69.10 MANIA | 5 0.05 69.15 MANTLE CELL LYMPHOMA | 7 0.07 69.22 MASTITIS | 2 0.02 69.24 MASTOCYTOSIS | 1 0.01 69.25 MEDICAL DIET | 7 0.07 69.32 MENINGITIS | 1 0.01 69.33 MENINGITIS BACTERIAL | 2 0.02 69.35 MENINGITIS COCCIDIOIDES | 1 0.01 69.36 MENINGITIS CRYPTOCOCCAL | 2 0.02 69.38 MENINGITIS MENINGOCOCCAL | 1 0.01 69.39 MENOMETRORRHAGIA | 1 0.01 69.40 MENOPAUSAL SYMPTOMS | 17 0.17 69.57 MENOPAUSE | 2 0.02 69.59 MENORRHAGIA | 7 0.07 69.66 MENSTRUAL DISCOMFORT | 1 0.01 69.67 MENSTRUAL DISORDER | 1 0.01 69.68 MENSTRUATION IRREGULAR | 3 0.03 69.71 MENTAL DISORDER | 12 0.12 69.83 MENTAL RETARDATION | 1 0.01 69.84 MESOTHELIOMA | 5 0.05 69.89 METASTASES TO BONE | 23 0.23 70.12 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 70.13 METASTASES TO LIVER | 2 0.02 70.15 METASTASES TO LYMPH NODES | 3 0.03 70.18 METASTASIS | 1 0.01 70.19 METASTATIC GASTRIC CANCER | 3 0.03 70.22 METASTATIC RENAL CELL CARCINOMA | 17 0.17 70.39 METASTATIC SQUAMOUS CELL CARCINOMA | 3 0.03 70.42 METRORRHAGIA | 2 0.02 70.44 MICROVASCULAR ANGINA | 1 0.01 70.45 MIDDLE INSOMNIA | 26 0.26 70.71 MIDDLE LOBE SYNDROME | 1 0.01 70.72 MIGRAINE | 15 0.15 70.87 MIGRAINE PROPHYLAXIS | 3 0.03 70.90 MIGRAINE WITH AURA | 1 0.01 70.91 MINERAL SUPPLEMENTATION | 4 0.04 70.95 MITRAL VALVE PROLAPSE | 2 0.02 70.97 MITRAL VALVE REPLACEMENT | 1 0.01 70.98 MONOCLONAL ANTIBODY UNCONJUGATED THER.. | 1 0.01 70.99 MOOD ALTERED | 1 0.01 71.00 MOTION SICKNESS | 6 0.06 71.06 MOTOR NEURONE DISEASE | 1 0.01 71.07 MUCOPOLYSACCHARIDOSIS I | 1 0.01 71.08 MUCOPOLYSACCHARIDOSIS II | 1 0.01 71.09 MUCOPOLYSACCHARIDOSIS VI | 1 0.01 71.10 MUCORMYCOSIS | 4 0.04 71.14 MUCOSAL INFLAMMATION | 1 0.01 71.15 MULTIPLE ALLERGIES | 39 0.39 71.54 MULTIPLE MYELOMA | 106 1.06 72.60 MULTIPLE SCLEROSIS | 135 1.35 73.95 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 73.96 MULTIPLE-DRUG RESISTANCE | 1 0.01 73.97 MUSCLE DISORDER | 1 0.01 73.98 MUSCLE RELAXANT THERAPY | 5 0.05 74.03 MUSCLE RIGIDITY | 1 0.01 74.04 MUSCLE SPASMS | 8 0.08 74.12 MUSCLE SPASTICITY | 18 0.18 74.30 MUSCULOSKELETAL CHEST PAIN | 1 0.01 74.31 MUSCULOSKELETAL PAIN | 9 0.09 74.40 MUSCULOSKELETAL STIFFNESS | 1 0.01 74.41 MYALGIA | 5 0.05 74.46 MYASTHENIA GRAVIS | 2 0.02 74.48 MYCOSIS FUNGOIDES | 3 0.03 74.51 MYDRIASIS | 2 0.02 74.53 MYELODYSPLASTIC SYNDROME | 17 0.17 74.70 MYELOFIBROSIS | 1 0.01 74.71 MYOCARDIAL INFARCTION | 15 0.15 74.86 MYOCLONIC EPILEPSY | 5 0.05 74.91 MYOCLONUS | 2 0.02 74.93 NASAL CONGESTION | 7 0.07 75.00 NASAL DRYNESS | 1 0.01 75.01 NASAL POLYPS | 2 0.02 75.03 NASOPHARYNGEAL CANCER | 1 0.01 75.04 NASOPHARYNGITIS | 15 0.15 75.19 NAUSEA | 35 0.35 75.54 NECK PAIN | 4 0.04 75.58 NEONATAL RESPIRATORY DISTRESS SYNDROME | 4 0.04 75.62 NEOPLASM | 1 0.01 75.63 NEOPLASM MALIGNANT | 3 0.03 75.66 NEPHROPATHY | 1 0.01 75.67 NEPHROTIC SYNDROME | 5 0.05 75.72 NERVE COMPRESSION | 1 0.01 75.73 NERVOUSNESS | 3 0.03 75.76 NEURALGIA | 12 0.12 75.88 NEUROBLASTOMA | 3 0.03 75.91 NEUROMUSCULAR BLOCKADE | 4 0.04 75.95 NEUROMUSCULAR BLOCKADE REVERSAL | 1 0.01 75.96 NEUROPATHY PERIPHERAL | 12 0.12 76.08 NEUROSIS | 1 0.01 76.09 NEUTROPENIA | 19 0.19 76.28 NOCTURIA | 1 0.01 76.29 NOCTURNAL DYSPNOEA | 1 0.01 76.30 NON-HODGKIN'S LYMPHOMA | 25 0.25 76.55 NON-SMALL CELL LUNG CANCER | 55 0.55 77.10 NON-SMALL CELL LUNG CANCER METASTATIC | 3 0.03 77.13 NON-SMALL CELL LUNG CANCER STAGE II | 1 0.01 77.14 NON-SMALL CELL LUNG CANCER STAGE IV | 1 0.01 77.15 NUCLEAR MAGNETIC RESONANCE IMAGING | 29 0.29 77.44 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 77.46 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 8 0.08 77.54 NUTRITIONAL SUPPORT | 8 0.08 77.62 OBESITY | 6 0.06 77.68 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 77.70 OBSTRUCTION | 1 0.01 77.71 OCULAR HYPERTENSION | 2 0.02 77.73 OEDEMA | 8 0.08 77.81 OEDEMA PERIPHERAL | 2 0.02 77.83 OESOPHAGEAL ADENOCARCINOMA | 5 0.05 77.88 OESOPHAGEAL CARCINOMA | 3 0.03 77.91 OESOPHAGEAL FISTULA | 4 0.04 77.95 OESOPHAGITIS | 3 0.03 77.98 OESTROGEN REPLACEMENT THERAPY | 6 0.06 78.04 OFF LABEL USE | 6 0.06 78.10 OLIGODENDROGLIOMA | 1 0.01 78.11 ONYCHOMYCOSIS | 4 0.04 78.15 OPEN ANGLE GLAUCOMA | 1 0.01 78.16 OPHTHALMOLOGICAL EXAMINATION | 1 0.01 78.17 OPPORTUNISTIC INFECTION PROPHYLAXIS | 2 0.02 78.19 ORAL CANDIDIASIS | 1 0.01 78.20 ORAL CONTRACEPTION | 10 0.10 78.30 ORAL HERPES | 1 0.01 78.31 ORGASM ABNORMAL | 2 0.02 78.33 ORTHOSTATIC HYPOTENSION | 1 0.01 78.34 OSTEITIS | 5 0.05 78.39 OSTEOARTHRITIS | 13 0.13 78.52 OSTEODYSTROPHY | 1 0.01 78.53 OSTEOMYELITIS | 3 0.03 78.56 OSTEONECROSIS | 1 0.01 78.57 OSTEOPENIA | 16 0.16 78.73 OSTEOPOROSIS | 115 1.15 79.88 OSTEOPOROSIS POSTMENOPAUSAL | 4 0.04 79.92 OSTEOPOROSIS PROPHYLAXIS | 5 0.05 79.97 OVARIAN CANCER | 18 0.18 80.15 OVARIAN CANCER RECURRENT | 1 0.01 80.16 OVARIAN CYST | 1 0.01 80.17 OVARIAN DISORDER | 1 0.01 80.18 OVARIAN EPITHELIAL CANCER | 1 0.01 80.19 OVARIAN FAILURE | 1 0.01 80.20 OVERDOSE | 2 0.02 80.22 PAIN | 169 1.69 81.91 PAIN IN EXTREMITY | 5 0.05 81.96 PAIN MANAGEMENT | 11 0.11 82.07 PALPITATIONS | 2 0.02 82.09 PANCREATIC CARCINOMA | 19 0.19 82.28 PANCREATIC CARCINOMA METASTATIC | 1 0.01 82.29 PANCREATIC DISORDER | 1 0.01 82.30 PANCREATIC INSUFFICIENCY | 1 0.01 82.31 PANCREATITIS CHRONIC | 3 0.03 82.34 PANIC ATTACK | 6 0.06 82.40 PANIC DISORDER | 3 0.03 82.43 PARENTERAL NUTRITION | 11 0.11 82.54 PARKINSON'S DISEASE | 91 0.91 83.45 PARKINSONISM | 3 0.03 83.48 PARTIAL SEIZURES | 2 0.02 83.50 PATENT DUCTUS ARTERIOSUS | 2 0.02 83.52 PELVIC INFLAMMATORY DISEASE | 3 0.03 83.55 PELVIC MASS | 1 0.01 83.56 PEPTIC ULCER | 1 0.01 83.57 PERCUTANEOUS CORONARY INTERVENTION | 1 0.01 83.58 PERICARDIAL EFFUSION | 2 0.02 83.60 PERIPHERAL REVASCULARISATION | 1 0.01 83.61 PERIPHERAL VASCULAR DISORDER | 2 0.02 83.63 PERITONEAL DIALYSIS | 38 0.38 84.01 PERITONITIS | 4 0.04 84.05 PERITONITIS BACTERIAL | 2 0.02 84.07 PHARYNGITIS | 3 0.03 84.10 PHARYNGITIS STREPTOCOCCAL | 4 0.04 84.14 PHARYNGOLARYNGEAL PAIN | 3 0.03 84.17 PHYTOTHERAPY | 2 0.02 84.19 PITUITARY TUMOUR BENIGN | 3 0.03 84.22 PLATELET AGGREGATION INHIBITION | 1 0.01 84.23 PLEURAL EFFUSION | 1 0.01 84.24 PLEURAL MESOTHELIOMA | 2 0.02 84.26 PLEURAL MESOTHELIOMA MALIGNANT | 4 0.04 84.30 PLEURISY | 1 0.01 84.31 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 84.33 PNEUMONIA | 33 0.33 84.66 PNEUMONIA ASPIRATION | 2 0.02 84.68 PNEUMONIA FUNGAL | 2 0.02 84.70 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 84.71 POLLAKIURIA | 2 0.02 84.73 POLYARTHRITIS | 1 0.01 84.74 POLYCYSTIC OVARIES | 4 0.04 84.78 POLYCYTHAEMIA VERA | 1 0.01 84.79 POLYMYALGIA RHEUMATICA | 2 0.02 84.81 POLYMYOSITIS | 2 0.02 84.83 POLYP | 1 0.01 84.84 POLYURIA | 2 0.02 84.86 POOR PERIPHERAL CIRCULATION | 1 0.01 84.87 POOR QUALITY SLEEP | 4 0.04 84.91 POST GASTRIC SURGERY SYNDROME | 1 0.01 84.92 POST-TRAUMATIC STRESS DISORDER | 2 0.02 84.94 POSTOPERATIVE ANALGESIA | 1 0.01 84.95 POSTOPERATIVE CARE | 1 0.01 84.96 POSTPARTUM DEPRESSION | 2 0.02 84.98 POSTURAL ORTHOSTATIC TACHYCARDIA SYND.. | 3 0.03 85.01 PRE-EXISTING DISEASE | 1 0.01 85.02 PRECOCIOUS PUBERTY | 1 0.01 85.03 PREGNANCY | 4 0.04 85.07 PREMATURE AGEING | 1 0.01 85.08 PREMATURE BABY | 2 0.02 85.10 PREMATURE MENOPAUSE | 1 0.01 85.11 PREMEDICATION | 36 0.36 85.47 PREMENSTRUAL SYNDROME | 2 0.02 85.49 PRENATAL CARE | 1 0.01 85.50 PREOPERATIVE CARE | 1 0.01 85.51 PROCEDURAL NAUSEA | 1 0.01 85.52 PROCOAGULANT THERAPY | 2 0.02 85.54 PROCTALGIA | 1 0.01 85.55 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 85.56 PROLACTINOMA | 1 0.01 85.57 PROPHYLAXIS | 112 1.12 86.69 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 7 0.07 86.76 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 12 0.12 86.88 PROPHYLAXIS AGAINST MOTION SICKNESS | 1 0.01 86.89 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 8 0.08 86.97 PROPHYLAXIS OF NAUSEA AND VOMITING | 5 0.05 87.02 PROPHYLAXIS URINARY TRACT INFECTION | 1 0.01 87.03 PROSTATE CANCER | 30 0.30 87.33 PROSTATE CANCER METASTATIC | 6 0.06 87.39 PROSTATE CANCER STAGE I | 2 0.02 87.41 PROSTATIC DISORDER | 2 0.02 87.43 PROSTATISM | 2 0.02 87.45 PROSTATITIS | 1 0.01 87.46 PROSTATOMEGALY | 2 0.02 87.48 PROTEINURIA | 1 0.01 87.49 PROTHROMBIN TIME PROLONGED | 1 0.01 87.50 PRURITUS | 8 0.08 87.58 PSEUDOMONAL SEPSIS | 1 0.01 87.59 PSORIASIS | 22 0.22 87.81 PSORIATIC ARTHROPATHY | 13 0.13 87.94 PSYCHOSOMATIC DISEASE | 1 0.01 87.95 PSYCHOTIC DISORDER | 11 0.11 88.06 PTERYGIUM | 1 0.01 88.07 PULMONARY CONGESTION | 1 0.01 88.08 PULMONARY EMBOLISM | 6 0.06 88.14 PULMONARY FIBROSIS | 2 0.02 88.16 PULMONARY HYPERTENSION | 19 0.19 88.35 PULMONARY MASS | 1 0.01 88.36 PULMONARY TUBERCULOSIS | 2 0.02 88.38 PYODERMA GANGRENOSUM | 1 0.01 88.39 PYREXIA | 18 0.18 88.57 RADIATION PNEUMONITIS | 1 0.01 88.58 RADIOISOTOPE SCAN | 2 0.02 88.60 RASH | 2 0.02 88.62 RAYNAUD'S PHENOMENON | 1 0.01 88.63 RECTAL CANCER | 15 0.15 88.78 RECTAL CANCER METASTATIC | 1 0.01 88.79 RECTAL SPASM | 1 0.01 88.80 RED MAN SYNDROME | 2 0.02 88.82 REFLUX OESOPHAGITIS | 2 0.02 88.84 REFRACTORY ANAEMIA WITH AN EXCESS OF .. | 2 0.02 88.86 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 4 0.04 88.90 RELAXATION THERAPY | 1 0.01 88.91 RENAL CANCER METASTATIC | 1 0.01 88.92 RENAL CELL CARCINOMA | 57 0.57 89.49 RENAL CELL CARCINOMA STAGE III | 4 0.04 89.53 RENAL CELL CARCINOMA STAGE IV | 3 0.03 89.56 RENAL CYST | 1 0.01 89.57 RENAL DISORDER | 2 0.02 89.59 RENAL FAILURE | 1 0.01 89.60 RENAL FAILURE CHRONIC | 9 0.09 89.69 RENAL IMPAIRMENT | 1 0.01 89.70 RENAL TRANSPLANT | 44 0.44 90.14 RESORPTION BONE INCREASED | 2 0.02 90.16 RESPIRATORY DISORDER | 1 0.01 90.17 RESPIRATORY DISTRESS | 1 0.01 90.18 RESPIRATORY FAILURE | 4 0.04 90.22 RESPIRATORY TRACT CONGESTION | 1 0.01 90.23 RESPIRATORY TRACT INFECTION | 6 0.06 90.29 RESTLESS LEGS SYNDROME | 12 0.12 90.41 RESTLESSNESS | 3 0.03 90.44 RHEUMATOID ARTHRITIS | 266 2.66 93.10 RHINITIS | 2 0.02 93.12 RHINITIS ALLERGIC | 4 0.04 93.16 ROAD TRAFFIC ACCIDENT | 1 0.01 93.17 ROSACEA | 7 0.07 93.24 ROUTINE HEALTH MAINTENANCE | 2 0.02 93.26 SARCOIDOSIS | 1 0.01 93.27 SCAN BRAIN | 1 0.01 93.28 SCAN MYOCARDIAL PERFUSION | 1 0.01 93.29 SCAN WITH CONTRAST | 1 0.01 93.30 SCAR | 1 0.01 93.31 SCHIZOAFFECTIVE DISORDER | 2 0.02 93.33 SCHIZOPHRENIA | 45 0.45 93.78 SCHIZOPHRENIA, PARANOID TYPE | 6 0.06 93.84 SCHIZOPHRENIA, UNDIFFERENTIATED TYPE | 1 0.01 93.85 SCIATICA | 2 0.02 93.87 SCLERODERMA | 1 0.01 93.88 SEASONAL ALLERGY | 11 0.11 93.99 SECONDARY HYPERTENSION | 2 0.02 94.01 SECONDARY HYPOTHYROIDISM | 1 0.01 94.02 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 2 0.02 94.04 SECRETION DISCHARGE | 1 0.01 94.05 SEDATION | 4 0.04 94.09 SEDATIVE THERAPY | 8 0.08 94.17 SEPSIS | 20 0.20 94.37 SEPTIC SHOCK | 3 0.03 94.40 SERUM FERRITIN INCREASED | 1 0.01 94.41 SEXUAL DYSFUNCTION | 1 0.01 94.42 SICKLE CELL ANAEMIA | 3 0.03 94.45 SINUSITIS | 7 0.07 94.52 SJOGREN'S SYNDROME | 2 0.02 94.54 SKIN DISORDER | 4 0.04 94.58 SKIN INFECTION | 2 0.02 94.60 SKIN LESION | 1 0.01 94.61 SKIN REACTION | 1 0.01 94.62 SKIN WRINKLING | 7 0.07 94.69 SLEEP APNOEA SYNDROME | 2 0.02 94.71 SLEEP DISORDER | 33 0.33 95.04 SLEEP DISORDER THERAPY | 2 0.02 95.06 SMALL CELL LUNG CANCER EXTENSIVE STAGE | 1 0.01 95.07 SMALL CELL LUNG CANCER METASTATIC | 2 0.02 95.09 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 3 0.03 95.12 SMOKING CESSATION THERAPY | 77 0.77 95.89 SOMATOFORM DISORDER | 1 0.01 95.90 SOMNOLENCE | 2 0.02 95.92 SPINAL DISORDER | 3 0.03 95.95 SPINAL MUSCULAR ATROPHY | 1 0.01 95.96 SPINAL MYELOGRAM | 1 0.01 95.97 SPINAL OSTEOARTHRITIS | 1 0.01 95.98 SPONDYLITIS | 2 0.02 96.00 SQUAMOUS CELL CARCINOMA | 20 0.20 96.20 STAPHYLOCOCCAL ABSCESS | 1 0.01 96.21 STAPHYLOCOCCAL INFECTION | 7 0.07 96.28 STAPHYLOCOCCAL SEPSIS | 6 0.06 96.34 STATUS EPILEPTICUS | 1 0.01 96.35 STEM CELL TRANSPLANT | 9 0.09 96.44 STENT PLACEMENT | 2 0.02 96.46 STOMACH DISCOMFORT | 3 0.03 96.49 STRESS | 4 0.04 96.53 STRESS FRACTURE | 1 0.01 96.54 STRESS ULCER | 1 0.01 96.55 STRONGYLOIDIASIS | 1 0.01 96.56 SUBMANDIBULAR MASS | 1 0.01 96.57 SUICIDAL IDEATION | 1 0.01 96.58 SUICIDE ATTEMPT | 2 0.02 96.60 SUPPLEMENTATION THERAPY | 19 0.19 96.79 SUPRAVENTRICULAR TACHYCARDIA | 5 0.05 96.84 SURGERY | 2 0.02 96.86 SWEAT GLAND INFECTION | 1 0.01 96.87 SWELLING | 3 0.03 96.90 SYSTEMIC LUPUS ERYTHEMATOSUS | 18 0.18 97.08 SYSTEMIC SCLEROSIS | 1 0.01 97.09 SYSTOLIC HYPERTENSION | 1 0.01 97.10 T-CELL DEPLETION | 1 0.01 97.11 T-CELL LYMPHOMA | 1 0.01 97.12 TACHYCARDIA | 4 0.04 97.16 TAKAYASU'S ARTERITIS | 2 0.02 97.18 TENOSYNOVITIS | 2 0.02 97.20 TESTIS CANCER | 3 0.03 97.23 THALASSAEMIA | 1 0.01 97.24 THERAPEUTIC PROCEDURE | 1 0.01 97.25 THROMBECTOMY | 1 0.01 97.26 THROMBOCYTOPENIA | 1 0.01 97.27 THROMBOSIS | 6 0.06 97.33 THROMBOSIS PROPHYLAXIS | 21 0.21 97.54 THYROID CANCER | 1 0.01 97.55 THYROID CANCER METASTATIC | 1 0.01 97.56 THYROID DISORDER | 6 0.06 97.62 TINEA PEDIS | 2 0.02 97.64 TOBACCO ABUSE | 3 0.03 97.67 TOBACCO USER | 1 0.01 97.68 TOCOLYSIS | 6 0.06 97.74 TONSILLITIS | 2 0.02 97.76 TOOTH ABSCESS | 3 0.03 97.79 TRACHEITIS | 2 0.02 97.81 TRANSIENT ISCHAEMIC ATTACK | 2 0.02 97.83 TRANSPLANT | 5 0.05 97.88 TRAUMATIC HAEMORRHAGE | 2 0.02 97.90 TREMOR | 2 0.02 97.92 TRIGEMINAL NEURALGIA | 6 0.06 97.98 TROPONIN I INCREASED | 1 0.01 97.99 TUBERCULIN TEST | 6 0.06 98.05 TUBERCULIN TEST POSITIVE | 1 0.01 98.06 TUBERCULOSIS | 3 0.03 98.09 TURNER'S SYNDROME | 3 0.03 98.12 TYPE 1 DIABETES MELLITUS | 11 0.11 98.23 TYPE 2 DIABETES MELLITUS | 33 0.33 98.56 TYPE IIA HYPERLIPIDAEMIA | 3 0.03 98.59 ULCER | 4 0.04 98.63 ULTRASOUND DOPPLER | 1 0.01 98.64 UNEVALUABLE EVENT | 6 0.06 98.70 UPPER RESPIRATORY TRACT INFECTION | 9 0.09 98.79 UPPER RESPIRATORY TRACT INFLAMMATION | 10 0.10 98.89 URGE INCONTINENCE | 1 0.01 98.90 URINARY INCONTINENCE | 1 0.01 98.91 URINARY TRACT DISORDER | 2 0.02 98.93 URINARY TRACT INFECTION | 15 0.15 99.08 URINE FLOW DECREASED | 1 0.01 99.09 UROGRAM | 1 0.01 99.10 URTICARIA | 4 0.04 99.14 URTICARIA CHRONIC | 1 0.01 99.15 UTERINE LEIOMYOMA | 1 0.01 99.16 VAGINAL CANCER | 2 0.02 99.18 VARICELLA | 2 0.02 99.20 VASCULAR DEMENTIA | 1 0.01 99.21 VASCULAR GRAFT | 2 0.02 99.23 VASCULITIS | 2 0.02 99.25 VENOUS STASIS | 2 0.02 99.27 VENOUS THROMBOSIS | 3 0.03 99.30 VENTRICULAR ARRHYTHMIA | 4 0.04 99.34 VERTIGO | 3 0.03 99.37 VIPOMA | 2 0.02 99.39 VITAMIN B COMPLEX DEFICIENCY | 1 0.01 99.40 VITAMIN B12 DECREASED | 1 0.01 99.41 VITAMIN B12 DEFICIENCY | 2 0.02 99.43 VITAMIN SUPPLEMENTATION | 16 0.16 99.59 VOMITING | 10 0.10 99.69 VULVOVAGINAL DRYNESS | 1 0.01 99.70 WALDENSTROM'S MACROGLOBULINAEMIA | 4 0.04 99.74 WEIGHT CONTROL | 5 0.05 99.79 WEIGHT DECREASED | 3 0.03 99.82 WEIGHT LOSS DIET | 8 0.08 99.90 WHEEZING | 3 0.03 99.93 WOUND | 1 0.01 99.94 WOUND INFECTION | 2 0.02 99.96 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.97 WOUND TREATMENT | 2 0.02 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015